| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 1,019,900 | 992,600 | 1,030,200 | 952,200 | | Cost of Revenue | 236,800 | 230,300 | 243,100 | 237,200 | | | Gross Profit | 783,100 | 762,300 | 787,100 | 715,000 | | | Operating Expenses | | Research Development | 49,900 | 51,800 | 47,200 | 46,700 | | Selling General and Administrative | 425,300 | 430,700 | 435,600 | 404,900 | | Non Recurring | 11,400 |
-
| 64,600 | 53,100 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 296,500 | 279,800 | 239,700 | 210,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
| (4,200) | 28,200 | | Earnings Before Interest And Taxes | 296,500 | 279,800 | 235,500 | 238,500 | | Interest Expense | 4,000 | 3,700 |
-
|
-
| | Income Before Tax | 292,500 | 276,100 | 235,500 | 238,500 | | Income Tax Expense | 82,400 | 73,900 | 67,900 | 23,500 | | Minority Interest |
-
|
-
| (100) | (300) | | | | Net Income From Continuing Ops | 210,100 | 202,200 | 167,500 | 214,700 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 210,100 | 202,200 | 167,500 | 214,700 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $210,100 | $202,200 | $167,500 | $214,700 |
|
2.03% Nasdaq 
Income Statement
